CDC Issues $10 Million In Comparative Effectiveness Research Awards
Executive Summary
When it comes to comparative effectiveness research, the Centers for Disease Control and Prevention typically are not at the forefront of government agencies conducting activities in this space
You may also be interested in...
IOM Flags Top 100 Comparative Effectiveness Research Priorities; Drugs Mentioned Rarely
Among the top 25 priority CER topics, only five specifically mention including pharma or biotech products in the studies.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials